Dr. Dario Rusciano (born in 1955) has completed his PhD in Cell and Molecular Biology at Pisa University (Italy) in 1979. He has been involved as post-doc and project leader in basic research on the organ specificity of cancer metastasis at the Sclavo pharmaceutical company of Siena (Italy) from 1982 to 1989, and then at the Friedrich Miescher Institute of Basel (Switzerland) until the year 2000. He then shifted his interests towards translational research in ophthalmology, working as lab leader for the next 7 years in SIFI, a pharmaceurical Company based in Sicily (Italy), and then at Sooft, another pharmaceutical company now owned by Fidia Pharmaceuticals (Abano Terme, Italy), where he has been appointed research director for ophthalmology.

He has authored 80 papers published in international journals, and one book on the experimental approaches in cancer metastasis (Elsevier, 2000).

Editorial Board
Terms of Appointment: August 2020 - July 2022